DPP-1 inhibitors and macrolides likely reduce the frequency of exacerbations in patients with non-cystic fibrosis ...
Please provide your email address to receive an email when new articles are posted on . The meta-analysis included 20 randomized control trials with 2,067 participants. Patients who used macrolides ...
Background. Streptococcus pneumoniae (pneumococcus) colonizes mucosal surfaces of the upper respiratory tract (URT), resulting in invasive disease. Macrolides are known for their immunomodulatory ...
Please provide your email address to receive an email when new articles are posted on . Avoidance of cephalosporins and penicillin with beta-lactamase inhibitors during anti-TNF therapy reduced the ...
Macrolides are an important class of antibiotics that includes drugs such as azithromycin and erythromycin, which are widely ...
Bronchiolitis obliterans (BO) is a serious complication of hematopoietic SCT (HSCT). The condition is believed to be the result of an inflammatory part of the GVHD. Although many BO patients receive ...
Use of macrolide antibiotics during pregnancy slightly elevates the risk for cerebral palsy and/or epilepsy in children, according to an observational study published online March 25 in PLOS One.
Researchers have created the largest publicly available virtual library of macrolide scaffolds. The library -- called V1M -- contains chemical structures and computed properties for 1 million ...
Antibiotics are medications that treat bacterial infections. They achieve this by killing bacteria or slowing their growth. Some common types of antibiotics include penicillin and macrolides. Medical ...
Pregnant women who take certain types of antibiotics have a greater risk of having a child with birth defects, a study has found. Using data on over 100,000 children, researchers found that women ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Macrolide Pharmaceuticals, a next-generation antibiotics company developing macrolides that are first-in-class with Gram-negative activity for a broad range of multi ...